Cargando…
Taking part in a pharmacogenetic clinical trial: assessment of trial participants understanding of information disclosed during the informed consent process
BACKGROUND: This study is the first to examine the understandings that participants have of the consent process in a pharmacogenetic trial of anti-depressant medication. METHODS: This was a qualitative cross sectional study. There were 76 participants residing in London, Mannheim, Arhuus and Poznan....
Autores principales: | Rose, Diana, Russo, Jasna, Wykes, Til |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3847084/ https://www.ncbi.nlm.nih.gov/pubmed/24025622 http://dx.doi.org/10.1186/1472-6939-14-34 |
Ejemplares similares
-
The goldilocks conundrum: Disclosing discrimination risks in informed consent
por: Prince, Anya E. R., et al.
Publicado: (2022) -
Participant Informed Consent in Cluster Randomized Trials: Review
por: Giraudeau, Bruno, et al.
Publicado: (2012) -
Sense and readability: participant information sheets for research studies
por: Ennis, Liam, et al.
Publicado: (2016) -
A survey of study participants’ understanding of informed consent to participate in a randomised controlled trial of acupuncture
por: Smith, Caroline A., et al.
Publicado: (2016) -
Health literacy predicts participant understanding of orally-presented informed consent information
por: Ownby, Raymond L, et al.
Publicado: (2015)